S

SOGEMEFA (Public limited company)

BE 0452.574.581 Active ●Place Mac-Auliffe 18-19, 6600 Bastogne

SOGEMEFA is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0452.574.581. It was founded on 09-04-1994. Its registered office is in Bastogne. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2025 report equity of € 599 074 and a loss of € 32 007. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.

Information last updated on 07-10-2026.

Company information

Status
Active
Enterprise number
BE 0452.574.581
VAT registered
No
Founded
09-04-1994
Latest accounts
2025
Employees
-
Region
Wallonia
Establishments
1
Filing record
On time 4 of 4 years
Peppol e-invoicing
Not registered
Registered office
Place Mac-Auliffe 18-19, 6600 Bastogne
Main activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE activities
2110001 Etude, mise au point de la production des principes actifs destinés à la fabrication de médicaments
68201 Location et exploitation de biens immobiliers résidentiels propres ou loués, sauf logements sociaux
73200 Études de marché et sondages

Key figures of SOGEMEFA

202520242023
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -32 007-106 %€ -15 506€ 34 446
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 599 074-5 %€ 631 081-2 %€ 646 587
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 811 296-14 %€ 942 842-3 %€ 971 297
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ -22 185-242 %€ -6 482+46 %€ -11 971
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
---

Financial estimate

Financial health grade A, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
1 mandate on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity nearby.

CompanyTown
S.M.B. TECHNOLOGY 6900 Marche-en-Famenne
BELGIAN DIAGNOSTIC COMPANY 6900 Marche-en-Famenne
Association Interrégionale d'Experts 6760 Virton
GALEPHAR M/F 6900 Marche-en-Famenne
BIOGEM 6690 Vielsalm
PHARMACIE DE RECOGNE 6800 Libramont-Chevigny
ATB THERAPEUTICS 6900 Marche-en-Famenne
THYMOLUX 6900 Marche-en-Famenne
Looking for more information about SOGEMEFA?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is SOGEMEFA still active? Yes. The Crossroads Bank for Enterprises lists SOGEMEFA as active.

What is the VAT number of SOGEMEFA? SOGEMEFA is not registered for VAT. Its enterprise number is 0452.574.581.

When was SOGEMEFA founded? SOGEMEFA was founded on 09-04-1994.

What is the address of SOGEMEFA? The current registered office of SOGEMEFA is Place Mac-Auliffe 18-19, 6600 Bastogne.

When did SOGEMEFA last file annual accounts? The latest annual accounts of SOGEMEFA were filed on 19-03-2026.

Does SOGEMEFA file its annual accounts on time? Yes. SOGEMEFA filed its annual accounts within the legal deadline for each of its last 4 financial years.

Is SOGEMEFA financially healthy? Addrly gives SOGEMEFA a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is SOGEMEFA profitable? The annual accounts of SOGEMEFA for 2025 show a loss of € 32 007.

What is the equity of SOGEMEFA? The equity of SOGEMEFA was € 599 074 at the close of the 2025 financial year.

Who are the directors of SOGEMEFA? The annual accounts of SOGEMEFA record 1 mandate. The name, role and dates are visible with a free account.

Can SOGEMEFA receive Peppol e-invoices? SOGEMEFA is not registered on the Peppol network at the moment.

What does SOGEMEFA do? The main activity of SOGEMEFA is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.

Sources

How Addrly builds and refreshes this data